Radient Pharma Stock Price (OTCMKTS:RXPC)

Add to My Stocks
$0 $0 (0%) RXPC stock closing price Jul 04, 2014 (Closing)
Prev Close* : $0
Market Cap:
Day Low: $0
52 Week Low: $0.00
Open: $0
Volume: $0
Day High: $0
52 Week High: $0.00

Latest Stock Market News

Latest Articles

RXPC Stockcharts

View RXPC PE ratio, PS ratio stocks charts and compare with peers.
RXPC Chart
Note: Compare Radient Pharma stock price history with the index and industry peers.

Radient Pharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Radient Pharma Returns

(return on equity)

Radient Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

RXPC Industry Peers

Company Price Change (%)
Futureworld (FWDG)00 (0%)
Guided Therapeutics (GTHP)00 (0%)
Weikang Bio Tech (WKBT)0.020.01 (100%)
Unilife (UNISQ)0.020 (0%)
Stryker (SYK)169.411.63 (0.95%)
Boston Scientific (BSX)36.430.56 (1.51%)
Essilor International (ESLOY)66.230.3 (0.45%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
NEPTUNE WELLNES (NEPT)4.540.37 (8.87%)
Rockwell Medical (RMTI)4.290.33 (8.33%)
Cardiovascular Systems (CSII)36.071.3 (3.74%)
Chimerix (CMRX)3.690.11 (3.07%)
Meridian Bioscience (VIVO)15.160.44 (2.99%)
Perrigo (PRGO)71.821.66 (2.37%)
Utah Medical Products (UTMD)87.531.76 (2.05%)
Top gainers from Medical Products industry
* As of Oct 15, 2018
CompanyPriceChange (%)
BioLife Solutions (BLFS)12.290.6 (4.65%)
Insys Therapeutics (INSY)8.670.23 (2.58%)
Conatus Pharma (CNAT)4.860.11 (2.21%)
Boston Scientific (BSX)36.430.56 (1.51%)
TG Therapeutics (TGTX)5.50.08 (1.43%)
Bio-Rad Laboratories (BIO)277.783.9 (1.38%)
MacroGenics (MGNX)18.650.26 (1.37%)
Top losers from Medical Products industry
* As of Oct 15, 2018

Radient Pharma Financial Statements

income statement2011201020092008
Net Sales or Revenues--8.62M28.26M
Net Income-86.18M-85.71M-16.62M1.18M
Total Operating Expense10.11M13.61M10.93M11.24M
View Radient Pharma income statement
balance sheet2011201020092008
Total Assets1.17M-26.31M42.75M
Total Liabilities50.86M53.75M5.62M7.8M
Shareholders Equity-49.68M-52.89M20.69M34.94M
View Radient Pharma balance sheet
cash flow statement2011201020092008
Net Increase (Decrease) in Assets Liabilities--1.64M-10M
Net Cash from (used by) Operating Activities-5.65M-7.11M-3.1M-4.67M
Increase (Decrease) in Prop Plant And Equipment-0.03M-0.02M-1.74M-1.5M
View Radient Pharma cash flow statement

Radient Pharma Stock Message Board

An investor needs to spend $0 to buy RXPC stock, as the closing Radient Pharma stock price is $0. The total market value as denoted by $0.45M for Radient Pharma, is the market value of the company's outstanding shares. A value investor must look at the fundamentals of a stock, and perform Radient Pharma valuation, even though in the short-term, sentiment and current breaking news might affect Radient Pharma stock price.

Demand for a stock decides its stock market price. For example, if more investors want to buy RXPC stock than sell it, then Radient Pharma stock price goes up. Conversely, if more investors wanted to sell RXPC stock than buy it, there would be greater supply than demand, and the stock price would fall. 0 RXPC shares were traded yesterday, and Radient Pharma stock chart shows that the RXPC stock quote hit a day high of $0 and day low of $0. Radient Pharma paid 0.00 stock dividends to its shareholders during last quarter. One can observe stock price trends and check for volatility by checking Radient Pharma stock price history.

Related to Radient Pharma Stock Quotes

Stocks from Medical Products, Radient Pharma stock price history,